Skip to main content

Life Sciences

By Emily Olsen | 12:01 pm | February 22, 2023
The Copenhagen-based digital health company will work with Novartis to build digital health tools for chronic conditions where they see unmet needs and the potential for disease progression.
By Jessica Hagen | 11:16 am | February 21, 2023
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
By Jessica Hagen | 11:54 am | February 16, 2023
The funds will be used to expand its research and development teams in the U.S. and Israel.
By Emily Olsen | 12:47 pm | February 15, 2023
The Digital Medicine Society partnered with digital health and pharma players like the FDA, Janssen, GSK, Medable and THREAD to build a toolkit aimed at improving diversity in digital research.
By Emily Olsen | 01:52 pm | February 13, 2023
Marker Learning, which provides virtual assessments for learning disabilities, raised $15 million, and reproductive care company Twentyeight Health scored $8.3 million.
By Adam Ang | 12:22 am | February 10, 2023
It will be used to invest in specialised healthcare logistics and financing, among other plans.
By Emily Olsen | 12:15 pm | February 03, 2023
Austin Speier, chief strategy officer at Click Therapeutics, discusses the company's expanded partnership with Boehringer Ingelheim.
By Emily Olsen | 02:31 pm | February 02, 2023
Science 37 said the purchase will improve its clinical trial workflow and data interoperability capabilities.
By Jessica Hagen | 02:28 pm | January 31, 2023
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
By Jessica Hagen | 11:29 am | January 31, 2023
Cough-monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.